Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
62.55 EUR | -1.42% | +2.21% | -12.52% |
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Revenues | 3.67B | 3.55B | 3.67B | 5.01B | 3.25B | |||||
Other Revenues, Total | 12M | 37M | 42M | 88M | 89M | |||||
Total Revenues | 3.68B | 3.59B | 3.71B | 5.1B | 3.34B | |||||
Cost of Goods Sold, Total | 2.83B | 1.31B | 962M | 1.5B | 1.1B | |||||
Gross Profit | 851M | 2.28B | 2.75B | 3.61B | 2.24B | |||||
Selling General & Admin Expenses, Total | 201M | 1.87B | 1.68B | 2.02B | 1.86B | |||||
R&D Expenses | 25M | - | - | - | - | |||||
Depreciation & Amortization - (IS) | 289M | - | - | - | 240M | |||||
Amortization of Goodwill and Intangible Assets - (IS) | - | 281M | 259M | 271M | - | |||||
Other Operating Expenses | 57M | 90M | 50M | 81M | 121M | |||||
Other Operating Expenses, Total | 572M | 2.24B | 1.99B | 2.37B | 2.22B | |||||
Operating Income | 279M | 41M | 754M | 1.24B | 15M | |||||
Interest Expense, Total | -124M | -133M | -114M | -106M | -144M | |||||
Interest And Investment Income | 13M | 11M | 9M | 9M | 42M | |||||
Net Interest Expenses | -111M | -122M | -105M | -97M | -102M | |||||
Income (Loss) On Equity Invest. | -7M | 86M | 121M | 258M | 295M | |||||
Currency Exchange Gains (Loss) | -1M | -24M | 12M | 29M | 286M | |||||
Other Non Operating Income (Expenses) | -2M | 5M | -1M | 12M | -3M | |||||
EBT, Excl. Unusual Items | 158M | -14M | 781M | 1.44B | 491M | |||||
Restructuring Charges | -16M | -8M | - | -2M | -5M | |||||
Impairment of Goodwill | - | -1M | - | - | - | |||||
Gain (Loss) On Sale Of Investments | 0 | -27M | -7M | -7M | 4M | |||||
Gain (Loss) On Sale Of Assets | - | 2M | -1M | - | - | |||||
Asset Writedown | -25M | -493M | 117M | -221M | -218M | |||||
Other Unusual Items | -35M | -14M | -1M | -16M | -172M | |||||
EBT, Incl. Unusual Items | 82M | -555M | 889M | 1.19B | 100M | |||||
Income Tax Expense | 227M | 121M | 98M | 264M | 88M | |||||
Earnings From Continuing Operations | -145M | -676M | 791M | 930M | 12M | |||||
Earnings Of Discontinued Operations | - | - | -426M | -156M | 6M | |||||
Net Income to Company | -145M | -676M | 365M | 774M | 18M | |||||
Minority Interest | -39M | 1M | -67M | -34M | 91M | |||||
Net Income - (IS) | -184M | -675M | 298M | 740M | 109M | |||||
Net Income to Common Incl Extra Items | -184M | -675M | 298M | 740M | 109M | |||||
Net Income to Common Excl. Extra Items | -184M | -675M | 724M | 896M | 103M | |||||
Per Share Items | ||||||||||
Net EPS - Basic | -6.94 | -25.47 | 10.43 | 25.81 | 3.81 | |||||
Basic EPS - Continuing Operations | -6.94 | -25.47 | 25.34 | 31.25 | 3.6 | |||||
Basic Weighted Average Shares Outstanding | 26.53M | 26.51M | 28.57M | 28.67M | 28.59M | |||||
Net EPS - Diluted | -6.94 | -25.47 | 10.39 | 25.47 | 3.75 | |||||
Diluted EPS - Continuing Operations | -6.94 | -25.47 | 25.24 | 30.84 | 3.54 | |||||
Diluted Weighted Average Shares Outstanding | 26.53M | 26.51M | 28.69M | 29.04M | 28.94M | |||||
Normalized Basic EPS | 2.25 | -0.29 | 14.74 | 30.2 | 13.92 | |||||
Normalized Diluted EPS | 2.25 | -0.29 | 14.68 | 29.82 | 13.75 | |||||
Dividend Per Share | - | - | 2.5 | 3.5 | 1.5 | |||||
Payout Ratio | -10.87 | -0.59 | 1.34 | 9.73 | 91.74 | |||||
American Depositary Receipts Ratio (ADR) | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | |||||
Supplemental Items | ||||||||||
EBITDA | 559M | 312M | 1.02B | 1.5B | 374M | |||||
EBITA | 303M | 68M | 794M | 1.28B | 50M | |||||
EBIT | 279M | 41M | 754M | 1.24B | 15M | |||||
Effective Tax Rate - (Ratio) | 276.83 | -21.8 | 11.02 | 22.11 | 88 | |||||
Total Current Taxes | 169M | 119M | 123M | 234M | 107M | |||||
Total Deferred Taxes | 58M | 2M | -25M | 30M | -19M | |||||
Normalized Net Income | 59.75M | -7.75M | 421M | 866M | 398M | |||||
Interest on Long-Term Debt | 18M | - | - | - | - | |||||
Non-Cash Pension Expense | 0 | 3M | -16M | 1M | 5M | |||||
Supplemental Operating Expense Items | ||||||||||
Research And Development Expense From Footnotes | 25M | - | - | - | - | |||||
Stock-Based Comp., SG&A Exp. (Total) | - | 6M | 6M | 8M | 11M | |||||
Stock-Based Comp., Other (Total) | 9M | - | - | - | - | |||||
Total Stock-Based Compensation | 9M | 6M | 6M | 8M | 11M |